Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Browse by Poster Presenter
Browse by Poster Presenter
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
T
Tabata, Takahiro
Sawai Pharmaceutical Co., Ltd.
(
T1030-01-01
)
Development of Physicochemical Profiling Platform for Therapeutic Oligonucleotides
Takahiro Tabata
Favorite
Taherian, Elham
University of Iowa
(
T1030-01-03
)
Stability of Therapeutic Monoclonal Antibodies during Infusion with Elastomeric Pumps Intended for Home-Based Therapy
Elham Taherian
Favorite
Takeuchi, Shoko
Takeda Pharnaceutical Company
(
T1030-01-01
)
Development of Physicochemical Profiling Platform for Therapeutic Oligonucleotides
Shoko Takeuchi
Favorite
Tang, Xiaonan
Frontage Laboratories, Inc.
(
W1530-02-11
)
Evaluation of API 7500 Integrated System with Microflow LC System M5 Using Sulfamethazine (SDX) Neat Solution
Xiaonan Tang
Favorite
Tanimoto, Masahiko
Mitsubishi Tanabe Pharma Corporation
(
W1030-01-01
)
Development of Physicochemical Profiling Platform for Therapeutic Oligonucleotides III Thermodynamic Analysis on Higher-Order Structure of Oligonucleotides
Masahiko Tanimoto
Favorite
Tao, Xun
Genentech, Inc.
(
T1430-02-08
)
Leveraging Buprenorphine as a Tool Molecule to Develop a Novel PBPK Model Accounting for Intestinal Lymphatic Absorption
Xun Tao
Favorite
(
T1530-02-07
)
Integrated HypoSkin® Model and PBPK Modeling as a Bioavailability Predicting Tool for Subcutaneous Delivery of Protein Therapeutics
Xun Tao
Favorite
Teleki, Alexandra
Uppsala University
(
W1030-02-08
)
Optimization of Artificial Colonic Mucus for Drug Diffusion Study
Alexandra Teleki
Favorite
Terrillon, Sonia
AstraZeneca
(
T1130-02-06
)
Biodistribution Analysis of GPC-3 CAR-T Cells in NSG Mice by a Universal ddPCR Assay to Support an IND-Enabling Toxicity Study
Sonia Terrillon
Favorite
Thite, Nidhi
University of Colorado Boulder
(
T1330-01-03
)
Stain-Free Approach to Determine and Monitor Cell Heath Using Supervised and Unsupervised Image-Based Deep Learning
Nidhi Thite
Favorite
Tian, Xuefei
Genentech, Inc.
(
T1330-02-07
)
Optimizing and Validating an In Vitro Transcytosis Assay for Predicting Pharmacokinetics in Drug Discovery and Process Development
Xuefei Tian
Favorite
Tia, Sameul
Correlia
(
T1330-02-10
)
Novel Immunoassay Technology: Evaluating the PIXI Platform for Rapid Quantitation with Automation, Wide Dynamic Range, and Small Sample Volume Requirement
Sameul Tia
Favorite
Tiwari, Rakesh
Western University of Health Sciences
(
W1030-02-09
)
Design and Evaluation of a Cyclic Peptide-Epirubicin Conjugate to Enhance Anticancer Activity and Reduce Cardiac Toxicity
Rakesh Tiwari
Favorite
Tjakra, Marco
Uppsala University
(
W1030-02-08
)
Optimization of Artificial Colonic Mucus for Drug Diffusion Study
Marco Tjakra
Favorite
Tomeh, Anas
LabCorp
(
T1330-01-02
)
Formulation Development and Characterization of a Marburg Self-amplifying mRNA-Lipid Nanoparticle Vaccine with a Toll-Like Receptor 7 Agonist
Anas Tomeh
Favorite
(
T1530-02-11
)
Formulation Development and Characterization of a Marburg Self-amplifying mRNA-Lipid Nanoparticle Vaccine with CpG Oligonucleotide
Anas Tomeh
Favorite
(
W1230-01-05
)
Development of a Marburg Self-amplifying mRNA-Lipid Nanoparticle Vaccine: Differential Effects When Co-formulated with Toll Receptor Agonists
Anas Tomeh
Favorite
Tomioka, Ryota
Shionogi & Co., Ltd.
(
T1230-02-06
)
Interlaboratory Study of Multi-Attribute Method (MAM) for Antibody Therapeutics – Overview
Ryota Tomioka
Favorite
(
T1430-02-06
)
Interlaboratory Study of Multi-Attribute Method (MAM) for Antibody Therapeutics – Post-Translational Modification (1) C-terminal Lys Clipping
Ryota Tomioka
Favorite
(
W1130-02-06
)
Interlaboratory Study of Multi-Attribute Method (MAM) for Antibody Therapeutics – Post-Translational Modification (2) Oxidation
Ryota Tomioka
Favorite
(
W1330-02-06
)
Interlaboratory Study of Multi-Attribute Method (MAM) for Antibody Therapeutics – Post-Translational Modification (1) Deamidation
Ryota Tomioka
Favorite
Tortoles, Daphne
NanoImaging Services
(
W1330-02-09
)
Using Cryo-TEM to Characterize Structural Details of LNPs during Manufacturing
Daphne Tortoles
Favorite
Tran, Vy
Genentech, Inc.
(
T1430-01-03
)
Val-His-Ser (VHS) N-terminal Leader Sequence and Implications for mAb Subcutaneous Pharmacokinetics
Vy Tran
Favorite
Trujillo, Adriana
NanoImaging Services
(
W1330-02-09
)
Using Cryo-TEM to Characterize Structural Details of LNPs during Manufacturing
Adriana Trujillo
Favorite
Tsutsumi, Shiho
Eisai Co., Ltd.
(
T1330-01-01
)
Development of Physicochemical Profiling Platform for Therapeutic Oligonucleotides II Circular Dichroism Spectroscopy and Nuclear Magnetic Resonance Analysis for Determining Higher-Order Structure
Shiho Tsutsumi
Favorite
Tuberty-Vaughan, Emma
AstraZeneca
(
T1330-01-03
)
Stain-Free Approach to Determine and Monitor Cell Heath Using Supervised and Unsupervised Image-Based Deep Learning
Emma Tuberty-Vaughan
Favorite
